dostarlimab
gsk
what to do with msi-h larc?need more studies and more follow-up on dostarlimab trial! #wcgic2022 #crc #msi 
Medical oncology resident | PhD in biochemistry | 
Interests: geriatric oncology, GU and GI malignacies